19-45385923-A-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_006663.4(PPP1R13L):āc.1982T>Gā(p.Ile661Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,612,272 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000013 ( 0 hom., cov: 32)
Exomes š: 0.0000034 ( 0 hom. )
Consequence
PPP1R13L
NM_006663.4 missense
NM_006663.4 missense
Scores
8
7
4
Clinical Significance
Conservation
PhyloP100: 9.05
Genes affected
PPP1R13L (HGNC:18838): (protein phosphatase 1 regulatory subunit 13 like) IASPP is one of the most evolutionarily conserved inhibitors of p53 (TP53; MIM 191170), whereas ASPP1 (MIM 606455) and ASPP2 (MIM 602143) are activators of p53.[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.887
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PPP1R13L | NM_006663.4 | c.1982T>G | p.Ile661Ser | missense_variant | 10/13 | ENST00000360957.10 | |
PPP1R13L | NM_001142502.2 | c.1982T>G | p.Ile661Ser | missense_variant | 10/13 | ||
PPP1R13L | XM_017026177.2 | c.1982T>G | p.Ile661Ser | missense_variant | 11/14 | ||
PPP1R13L | XM_017026178.2 | c.1982T>G | p.Ile661Ser | missense_variant | 11/14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PPP1R13L | ENST00000360957.10 | c.1982T>G | p.Ile661Ser | missense_variant | 10/13 | 1 | NM_006663.4 | P1 | |
PPP1R13L | ENST00000418234.6 | c.1982T>G | p.Ile661Ser | missense_variant | 10/13 | 1 | P1 | ||
PPP1R13L | ENST00000587270.5 | n.1455T>G | non_coding_transcript_exon_variant | 3/6 | 1 | ||||
PPP1R13L | ENST00000589858.1 | n.181T>G | non_coding_transcript_exon_variant | 1/3 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151942Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
151942
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000815 AC: 2AN: 245378Hom.: 0 AF XY: 0.00000750 AC XY: 1AN XY: 133294
GnomAD3 exomes
AF:
AC:
2
AN:
245378
Hom.:
AF XY:
AC XY:
1
AN XY:
133294
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460330Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726408
GnomAD4 exome
AF:
AC:
5
AN:
1460330
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
726408
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151942Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74198
GnomAD4 genome
AF:
AC:
2
AN:
151942
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74198
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The c.1982T>G (p.I661S) alteration is located in exon 10 (coding exon 9) of the PPP1R13L gene. This alteration results from a T to G substitution at nucleotide position 1982, causing the isoleucine (I) at amino acid position 661 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
.;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Pathogenic
D;D
Sift4G
Uncertain
D;D
Polyphen
D;D
Vest4
MutPred
Gain of glycosylation at I661 (P = 0.0043);Gain of glycosylation at I661 (P = 0.0043);
MVP
MPC
1.2
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at